Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes.

Cancer
Rachel N CusatisKathryn E Flynn

Abstract

Allogeneic hematopoietic stem cell transplantation (alloHCT) is potentially curative but with known negative effects on quality of life. In the current study, the authors investigated whether patients expressed regret after undergoing HCT and the relationships between clinical outcomes and quality of life. Center for International Blood and Marrow Transplant Research data from 184 adults who completed the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) before undergoing alloHCT and at day 100 were used. Additional time points were 6 months and 12 months. Regret was measured using a FACT-BMT item not included in scoring: "I regret having the bone marrow transplant." The authors evaluated FACT-BMT scores and regret using Student t-tests. Covariance pattern models were used to determine predictors of regret over time, including baseline characteristics and post-alloHCT outcomes (acute or chronic graft-versus-host-disease, disease recurrence). At 100 days, 6 months, and 12 months, approximately 6% to 8% of patients expressed regret; a total of 15% expressed regret at any time point. Regret was found to be associated with lower FACT-BMT scores at 6 months and 12 months (P < .001). Higher baseline FACT-BMT a...Continue Reading

References

Jun 25, 1997·JAMA : the Journal of the American Medical Association·S CohenJ M Gwaltney
Apr 13, 2000·Annals of Surgical Oncology·D K PayneM J Massie
Nov 18, 2000·Social Work in Health Care·L F Berkman
Jul 18, 2003·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Kate R Lorig, Halsted Holman
Aug 21, 2003·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Jamie C BrehautDeb Feldman-Stewart
Oct 11, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jack A ClarkJames A Talcott
Jul 28, 2005·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Terry Connolly, Jochen Reb
Oct 26, 2005·Annals of Epidemiology·David R Holtgrave, Richard Crosby
Apr 28, 2006·The New England Journal of Medicine·Edward A Copelan
Jul 28, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Catherine E MosherWilliam H Redd
Apr 22, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Heather S L JimOxana Palesh
Sep 23, 2014·Bone Marrow Transplantation·A D'SouzaR Spellecy
Mar 16, 2016·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Maria Margarita Becerra PérezFrance Légaré
Oct 5, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lisa BriceIan Kerridge
Nov 29, 2016·JAMA : the Journal of the American Medical Association·Areej El-JawahriJennifer S Temel
Jul 1, 2017·F1000Research·Maxim Norkin, John R Wingard
Oct 17, 2017·Bone Marrow Transplantation·A D'SouzaA Derse
Mar 9, 2018·Bone Marrow Transplantation·Anita D'SouzaBronwen E Shaw
Jan 10, 2019·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Anna G LarsonErin S Costanzo
Feb 24, 2019·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Helene M SchoemansKim Schmit-Pokorny

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Medical Decision Making : an International Journal of the Society for Medical Decision Making
G WilliamsH Herrera
Intensive Care Medicine
Jennifer L McAdamKathleen A Puntillo
HEC Forum : an Interdisciplinary Journal on Hospitals' Ethical and Legal Issues
Giles Schofield
The Harvard Mental Health Letter
Michael Craig Miller
The New England Journal of Medicine
Jerome Groopman, Pamela Hartzband
© 2021 Meta ULC. All rights reserved